American billionaire Elon Musk's neurotechnology startup Neuralink has just announced that it has successfully implanted two chips into the human brain in one day for the first time.
This event is considered an important milestone in the development and commercialization of Neuralink's brain-computer interface technology, opening up the prospect of widespread application in the treatment of serious neurological diseases.
This information was posted on the website of multi-platform media company Teslarati, based in California (USA), specializing in providing news, analysis and content related to companies founded by billionaire Elon Musk such as Tesla, SpaceX and related technologies.
According to an update released on the morning of July 21, US time, two patients identified as patients number 8 and number 9 were implanted with a chip device called “Link” over the weekend. This device is the size of a coin and is implanted into the human brain through invasive surgery.
Although Neuralink did not disclose the exact time of the surgery, it confirmed that both surgeries took place on the same day. Both patients are currently recovering well and are in good spirits.
According to Neuralink, the company's implant has "ultra-fine" fibers that help transmit signals in the brain of the patient who has the device implanted.
Billionaire Elon Musk - who co-founded Neuralink in 2016, emphasized that this technology could bring "revolutionary changes to millions, even billions of people."
Neuralink's neural implant technology is currently being tested on patients with amyotrophic lateral sclerosis (ALS) or cervical spinal cord injuries, diseases that can severely impair a patient's ability to move and communicate.
In the long term, Neuralink aims to expand its treatment to more common neurological disorders like anxiety, depression, or even cases of vision loss.
In May 2023, the US Food and Drug Administration (FDA) approved Neuralink to test chip implants in human brains. Then, in September, Neuralink was allowed to recruit paralyzed patients for a 6-year human brain implant trial.
Several companies are currently conducting similar research, including Sychron, based in Australia.
In July 2022, Sychron announced that it had implanted a brain-computer interface device into an ALS patient in the US. The purpose of implanting this device is to allow patients to communicate, even when they have lost the ability to move, by using their thoughts to send emails and messages./.
Source: https://www.vietnamplus.vn/neuralink-lan-dau-cay-chip-cho-2-benh-nhan-trong-ngay-post1051120.vnp
![[Infographic] Vietnam-Senegal traditional friendship](https://vphoto.vietnam.vn/thumb/1200x675/vietnam/resource/IMAGE/2025/7/23/4c96a604979345adb452af1d439d457b)
Comment (0)